Abstract The World Health Organization (WHO) declared COVID-19 as a pandemic on
March 11, 2020, because of its widespread transmission and infection rates. The unique …

Abstract Coronavirus disease 2019 (COVID-19) represents an unmet clinical need, due to a
high mortality rate, rapid mutation rate in the virus, increased chances of reinfection, lack of …

Obesity is associated with an increase in morbidity and mortality from coronavirus disease
2019 (COVID-19). The risk is related to the cytokine storm, a major contributor to multiorgan …

Background Safe and effective vaccination is considered to be the most critical strategy to
fight coronavirus disease 2019 (COVID-19), leading to individual and herd immunity …

Molnupiravir (MOV) and nirmatrelvir/ritonavir (NMV/r) are efficacious oral antiviral agents for
patients with the 2019 coronavirus (COVID-19). However, little is known about their …

Targeting structured RNA elements in the SARS-CoV-2 viral genome with small molecules
is an attractive strategy for pharmacological control over viral replication. In this work, we …

The infectious severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the
causative agent for coronavirus disease 2019 (COVID-19). Globally, there have been …

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)-induced disease
(COVID-19) and Gaucher disease (GD) exhibit upregulation of complement 5a (C5a) and its …

Background COVID-19 is an illness caused by severe acute respiratory syndrome
coronavirus 2. Due to its rapid spread, in March 2020 the World Health Organization (WHO) …

Background Although several studies have assessed the safety, efficacy, and effectiveness
of interventions in treating the COVID-19, many of them have limitations that can have an …